Nea Management Company, LLC X4 Pharmaceuticals, Inc Transaction History
Nea Management Company, LLC
- $1.6 Billion
- Q3 2025
A detailed history of Nea Management Company, LLC transactions in X4 Pharmaceuticals, Inc stock. As of the latest transaction made, Nea Management Company, LLC holds 2,233,743 shares of XFOR stock, worth $8.18 Million. This represents 0.47% of its overall portfolio holdings.
Number of Shares
2,233,743
Previous 499,559
347.14%
Holding current value
$8.18 Million
Previous $949,000
693.15%
% of portfolio
0.47%
Previous 0.08%
Shares
7 transactions
Others Institutions Holding XFOR
# of Institutions
11Shares Held
13.9MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY10.7MShares$39.1 Million0.0% of portfolio
-
Sv Health Investors, LLC Boston, MA311KShares$1.14 Million1.65% of portfolio
-
Acorn Capital Advisors, LLC New York, NY273KShares$1 Million0.47% of portfolio
-
Ajo Vista, LLC Boston, MA258KShares$942,9770.75% of portfolio
-
Minot Wealth Management LLC55KShares$201,3000.01% of portfolio
About X4 Pharmaceuticals, Inc
- Ticker XFOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,646,096
- Market Cap $251M
- Description
- X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...